XML 156 R161.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 27 - Quarterly Sales and Earnings Data - Unaudited (Details) - Quarterly Sales and Earnings Data (USD $)
In Millions, except Per Share data, unless otherwise specified
 3 Months Ended 1 Months Ended 3 Months Ended 4 Months Ended 2 Months Ended 3 Months Ended 4 Months Ended 8 Months Ended 12 Months Ended
Mar. 31, 2012
Sep. 30, 2013
Successor [Member]
Dec. 31, 2013
Successor [Member]
Dec. 31, 2013
Successor [Member]
Aug. 31, 2013
Predecessor [Member]
Jun. 30, 2013
Predecessor [Member]
Mar. 31, 2013
Predecessor [Member]
Dec. 31, 2012
Predecessor [Member]
Sep. 30, 2012
Predecessor [Member]
Jun. 30, 2012
Predecessor [Member]
Dec. 01, 2013
Predecessor [Member]
Aug. 31, 2013
Predecessor [Member]
Dec. 31, 2012
Predecessor [Member]
Dec. 31, 2011
Predecessor [Member]
2013                            
Net sales from continuing operations   $ 198 $ 607   $ 365 $ 583 $ 594 $ 739 $ 660 $ 699 $ 621      
Gross profit from continuing operations   22 96 118 85 133 150 103 75 101 14 368 293 490
(Loss) earnings from continuing operations (6) (31) [1] (51) [2]   2,085 [3] (208) [4] 324 [5] (420) [6] (322) [7] (297) [8] (298) [9]      
Loss (earnings) from discontinued operations (10)   10 [10] (6) [10] 4 (78) [10] (16) [10] (41) [10] 18 [10] 10 [10] (2) [10] (68) [10] (135) (42) (25)
Net (loss) earnings attributable to Eastman Kodak Company   $ (18) $ (63) $ (81) $ 2,007 $ (224) $ 283 $ (402) $ (312) $ (299) $ (366) $ 2,066 $ (1,379) $ (764)
Basic and diluted net (loss) earnings per share attributable to Eastman Kodak Company common shareholders:                            
Continuing operations (in Dollars per share)   $ (0.67) $ (1.37) $ (2.04) $ 7.65 $ (0.76) $ 1.19 $ (1.54) $ (1.19) $ (1.09) $ (1.10) $ 8.08 $ (4.92) $ (2.75)
Discontinued operations (in Dollars per share)   $ 0.24 $ (0.14) $ 0.10 $ (0.29) $ (0.06) $ (0.15) $ 0.07 $ 0.04 $ (0.01) $ (0.25) $ (0.50) $ (0.15) $ (0.09)
Total (in Dollars per share)   $ (0.43) $ (1.51) $ (1.94) $ 7.36 $ (0.82) $ 1.04 $ (1.47) $ (1.15) $ (1.10) $ (1.35) $ 7.58 $ (5.07) $ (2.84)
[1] Includes pre-tax corporate components of pension and OPEB costs of $13 million (included in Cost of sales, SG&A, and R&D), which increased net earnings from continuing operations by $13 million; and $5 million of Reorganization items, net.
[2] Includes pre-tax restructuring charges of $13 million included in Restructuring costs and other which decreased net earnings by $12 million; pre-tax impairment charges of $8 million included in Other operating (expense) income which decreased net earnings by $8 million, corporate components of pension and OPEB costs of $54 million (included in Cost of sales, SG&A, and R&D), which increased net earnings from continuing operations by $54 million, gain on sales of assets of $6 million which increased net earnings from continuing operations by $5 million and $10 million of Reorganization items, net.
[3] Includes pre-tax corporate components of pension and OPEB costs of $16 million (included in Cost of sales, SG&A, and R&D), which increased net earnings from continuing operations by $16 million; and $2,217 million of income from Reorganization items, net.
[4] Includes pre-tax restructuring charges of $33 million ($4 million included in Cost of sales and $29 million included in Restructuring costs and other), which decreased net earnings from continuing operations by $31 million; corporate components of pension and OPEB costs of $14 million (included in Cost of sales, SG&A, and R&D), which increased net earnings from continuing operations by $14 million; and $72 million of Reorganization items, net.
[5] Includes pre-tax licensing revenue of $535 million which increased net earnings from continuing operations by $530 million ; restructuring charges of $13 million ($2 million included in Cost of sales and $11 million included in Restructuring costs and other), which decreased net earnings from continuing operations by $13 million; corporate components of pension and OPEB costs of $12 million (included in Cost of sales, SG&A, and R&D), which increased net earnings from continuing operations by $14 million; a pre-tax impairment charge of $77 million (included in Other operating expenses (income), net), which decreased net earnings from continuing operations by $55 million, gain on sales of assets of $34 million which increased net earnings from continuing operations by $28 million and $119 million of Reorganization items, net.
[6] Includes pre-tax restructuring charges of $25 million ($5 million included in Cost of sales and $20 million included in Restructuring costs and other), which decreased net earnings from continuing operations by $30 million; corporate components of pension and OPEB costs of $8 million (included in Cost of sales, SG&A, and R&D), which increased net earnings from continuing operations by $9 million, $35 million associated with the termination of a supply agreement which increased net earnings from continuing operations by $35 million, gain on sale of assets of $50 million which increased net earnings from continuing operations by $33 million and $539 million of Reorganization items, net.
[7] Includes pre-tax restructuring charges of $120 million ($9 million included in Cost of sales and $111 million included in Restructuring costs and other), which decreased net earnings from continuing operations by $113 million; corporate components of pension and OPEB costs of $6 million (included in Cost of sales, SG&A, and R&D) which decreased net earnings from continuing operations by $3 million and $56 million of Reorganization items, net.
[8] Includes pre-tax restructuring charges of $6 million ($2 million included in Cost of sales and $4 million included in Restructuring costs and other), which decreased net earnings from continuing operations by $6 million; corporate components of pension and OPEB costs of $5 million (included in Cost of sales, SG&A, and R&D) which decreased net earnings from continuing operations by $3 million and $160 million of Reorganization items, net.
[9] Includes pre-tax restructuring charges of $81 million ($1 million included in Cost of sales and $80 million included in Restructuring costs and other), which decreased net earnings from continuing operations by $77 million and $88 million of Reorganization items, net.
[10] Refer to Note 26, "Discontinued Operations," in the Notes to Financial Statements for a discussion regarding discontinued operations.